Experience - Creativity - Innovation

Emeriti Bio is a privately owned Swedish company that was founded in 2015.  The founders are all former AstraZeneca scientists representing a wide knowledge of pharmaceutical research and development, often with many years in leading positions, and with experience of taking innovative drugs to the market.

From left: Tomas Fex, Bengt Ohlsson, Jan Fryklund, Björn Wallmark, David Gustafsson

Björn Wallmark - Chairman of the Board, PhD in biochemistry, worked with AstraZeneca for 27 years, and Schering AG for 5 years.

Jan Fryklund - CEO, PhD in Pharmacology, 35 years within AstraZeneca, Department head for many years.

David Gustafsson - Member of the board, MD and PhD in pharmacology, worked with AstraZeneca for 28 years.

Tomas Fex - Member of the Board, PhD in organic chemistry, 30 years of experience from pharmaceutical companies in Sweden, 10 years at AstraZeneca.

Bengt Ohlsson - PhD in organic chemistry, worked with AstraZeneca for 25 years.

Lars Gustafsson - Member of the Board, previous managing director and chairman of the Nordic branch of Euler Hermes, a credit insurance company.


Registered drugs and brands that we have had a major influence on: Losec®/Prilosec®, Nexium®, Plendil®, Exanta®, Brilinta®


800 666 7777